INCONTESTABLE® Blog
April 19, 2024
Webinar
Advertising Self-Regulation in 2024: Q&A with NAD Vice President Laura Brett
January 30, 2024
Never miss an Insight.
Sign upEvent
3rd Annual Passport to Proficiency on the Essentials of Hatch-Waxman and BPCIA 3rd Annual Passport to Proficiency on the Essentials of Hatch-Waxman and BPCIA
October 10-26, 2023
Virtual
Federal Circuit IP Blog
Intent for Induced Infringement Is Not Negated by the Board’s Final Written Decision Finding Claims Unpatentable as Obvious Intent for Induced Infringement Is Not Negated by the Board’s Final Written Decision Finding Claims Unpatentable as Obvious
August 4, 2023
Prosecution First Blog
Obviousness and Written Description Take Down an Infringed Patent Obviousness and Written Description Take Down an Infringed Patent
June 30, 2023
Federal Circuit IP Blog
Parkinson’s Patent Invalid Based on Obviousness of Overlapping Ranges Parkinson’s Patent Invalid Based on Obviousness of Overlapping Ranges
April 20, 2023
Event
2023 Orange Book Listing Recent Developments 2023 Orange Book Listing Recent Developments
February 14, 2023
Webinar
Event
Patenting Pharmaceutical Drug Formulations: Withstanding Litigation and PTAB Challenges Patenting Pharmaceutical Drug Formulations: Withstanding Litigation and PTAB Challenges
September 1, 2022
Webinar
Articles
Latest Developments in IP Strategies for Pharmaceuticals Latest Developments in IP Strategies for Pharmaceuticals
Summer 2022
International Pharmaceutical IndustryIP Health Blog
Defendants Allowed to Hide the Ball on Their Combination of Prior Art References Defendants Allowed to Hide the Ball on Their Combination of Prior Art References
May 5, 2022
IP Health Blog
ANDA Specification Controls Infringement Analysis, Not Expert Testimony ANDA Specification Controls Infringement Analysis, Not Expert Testimony
March 10, 2022
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.